Gene therapy in pediatric patients with spinal muscular atrophy in Kazakhstan: Challenges and achievements
{{output}}
Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder that results from a low level of survival motor neuron (SMN) protein. Onasemnogene abeparvovec is an approved genetic therapy that consists of a viral vector that carries DNA encoding the SMN pr... ...
